ANDN has successfully developed an inhaled solution for the treatment of COPD (Chronic Obstructive Pulmonary Disease), which affects over 16 million patients in the USA alone, and is the No. 4 clinical cause of death after heart failure, cancer and stroke.
Disclaimer: I post on stocks that I own or am thinking about owning. Do your DD, buy and sell based on that DD.